Evidence map›Paper›PMID 32463542›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2020

Fragile X Gray Zone Alleles Are Associated With Signs of Parkinsonism and Earlier Death.

Deborah A Hall, Sukriti Nag, Bichun Ouyang, David A Bennett, Yuanqing Liu, Aisha Ali, Lili Zhou, Elizabeth Berry-Kravis

Open access · greenAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Beyond Repetition: The Role of Gray Zone Alleles in the Upregulation ofInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. FMR1 CGG Repeats and Stress Influence Self-Reported Cognitive Functioning in Mothers.American journal on intellectual and developmental disabilities · 2023
    Article
  10. Evaluation of the role ofFrontiers in aging neuroscience · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Screening forBioMed research international · 2021
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Deborah A HallDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Sukriti NagDepartment of Pathology, Rush University Medical Center, Chicago, Illinois, USA.
Bichun OuyangDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
David A BennettDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Yuanqing LiuDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Aisha AliUniversity of Illinois, Chicago, Illinois, USA.
Lili ZhouDepartment of Pediatrics, Rush University Medical Center, Chicago, Illinois, USA.
Elizabeth Berry-KravisDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Rush University Medical Center · USRush University · USUniversity of Illinois Urbana-Champaign · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI LEURGANS, SUE E. · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Adult Neurological Phenotypes of Fragile X Gray Zone ExpansionR01NS082416 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI HALL, DEBORAH A · 2013 to 2016
$1.2M
NIA NIH HHS P30 AG010161NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NINDS NIH HHS R01 NS082416
6 · The paper itself

Abstract

backgroundPremutation size (55-199 CGG repeats) in the fragile X mental retardation 1 (FMR1) gene cause fragile X-associated tremor/ataxia syndrome, but it is unclear whether smaller "gray" zone expansions of 41-54 repeats are also associated with movement disorders. The objectives of this study were to determine the association between the FMR1 gene gray zone expansions, AGG interspersions, and the presence of parkinsonism and motor and cognitive function in an elderly community-based population.

methodsAutomated FMR1 polymerase chain reaction was performed on existing samples from 2 longitudinal aging studies whose subjects agreed to brain donation. A detailed clinical evaluation including a modified Unified Parkinson's Disease Rating Scale score, a composite score of global motor function, 17 cognitive tests summarized as a global measure of cognition, and neuropathological examination were obtained for genotyped participants.

resultsThe average age of the population (n = 2362) was 85.9 ± 7.3 years, and average age at death was 88.6 ± 6.4 years (n = 1326), with 72% women. The prevalence of FMR1 gray zone alleles was 5.2% (122 of 2362). There was no difference between participants with gray zone expansions or those lacking AGG interspersions compared with normal participants in global cognition, global motor function, clinical diagnosis, or pathological changes. Gray zone alleles were associated with signs of parkinsonism in men (P = 0.01), and gray zone carrier men were more likely to die (hazard ratio, 2.34; 95% confidence interval, 1.31-4.16).

conclusionsThis is the largest study to investigate gray zone alleles in a community population. The key findings are that in men, the gray zone allele is associated with signs of parkinsonism and higher risk of death, but not with intranuclear neuronal inclusions. © 2020 International Parkinson and Movement Disorder Society.

Indexed as

Fragile X SyndromeParkinsonian DisordersAgedAged, 80 and overAllelesFemaleFragile X Messenger Ribonucleoprotein 1HumansMaleTrinucleotide Repeat ExpansionFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1atypical parkinsonismfragile XFXTAS

Identifiers

PMID32463542
PMCPMC10335806
OpenAlexW3031350664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.